Alnylam Pharmaceuticals

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.

About ALNY

Alnylam Pharmaceuticals, Inc. is a global commercial-stage biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. Its products include ONPATTRO, GIVLAARI, and OXLUMO.

CEO

Yvonne L. Greenstreet

CEOYvonne L. Greenstreet

Employees

1,665

Employees1,665

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2002

Founded2002

Employees

1,665

Employees1,665

ALNY Key Statistics

Market cap

29.31B

Market cap29.31B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

760.21K

Average volume760.21K

High today

—

High today—

Low today

—

Low today—

Open price

$207.21

Open price$207.21

Volume

0.00

Volume0.00

52 Week high

$236.80

52 Week high$236.80

52 Week low

$117.58

52 Week low$117.58

Analyst ratings

64%

of 25 ratings

Buy

64%

Hold

36%

Sell

ALNY Earnings

-$2.03

-$1.35

-$0.68

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Feb 9, Pre-Market

ActualExpected Feb 9, Pre-Market